Total Funding
56
49
Total FundingSeed raised
Growth Score
-4 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
132306
KuartisMED is a biomedical company that designs and develops medical products for the well-being of newborn children.
- Ahmet Saracoglu: Co-Founder/CEOPast Role: TÜBİTAK, Technical Leader
- Ayşe Nur Ecevit: Chief Clinical Officer and Co-Founder
About the Company
KuartisMED is a biomedical company developing products for the well-being of preterm infants. It developed Premades, a monitoring feeding ability for newborns.
KuartisMED is a proud Horizon 2020 SME Instrument grantee. Its banner product has received a Phase-2 grant for the “SMEInst-12-2016-2017 — New business models for inclusive, innovative and
reflective societies” which is awarded from the European Union’s Horizon 2020 research and innovation program. The company had previously received H2020 SME Instrument Phase-1 grant in 2014 for the Feasibility Study and Commercialization Plan for PREMADES.
